Severe vitamin D deficiency in patients admitted to the emergency department with severe sepsis is associated with an increased 90-day mortality

Background The role of vitamin D in the response to infection has been increasingly acknowledged. However, the influence of severe vitamin D deficiency on the outcome of patients admitted for severe sepsis is unknown. Hence, this study aimed to investigate the association between severe vitamin D deficiency and sepsis-related outcomes in patients presenting to the ED. Methods This single centre prospective study included patients presenting to the ED with severe sepsis from April 2014 until December 2017. 25-Hydroxy vitamin D (25(OH)D) was measured in a blood sample drawn within 24 hours of admission to the ED, and severe vitamin D deficiency was defined as 25(OH)D <12 ng/mL. 90-day mortality was compared between patients with and without severe vitamin D deficiency by a multivariable analysis adjusting for confounders and according to a Kaplan-Meier survival analysis. Results 263 patients were initially screened and 164 patients with severe sepsis were included in this study, 18% of whom had septic shock. Severe vitamin D deficiency was present in 46% of patients. The overall 90-day mortality rate was 26.2% and the median length of stay was 14 days. In a logistic regression accounting for sepsis severity and age-adjusted comorbidities, severe vitamin D deficiency was associated with increased mortality (OR=2.69 (95% CI 1.03 to 7.00), p=0.043), and lower chances of hospital discharge (sub-HR=0.66 (95% CI 0.44 to 0.98)). In the subgroup of patients admitted to the intensive care unit, severe vitamin D deficiency was associated with an increased 28-day adjusted mortality (HR=3.06 (95% CI 1.05 to 8.94), p=0.04) and lower chances of discharge (sub-HR=0.51 (95% CI 0.32 to 0.81)). Conclusions Severe vitamin D deficiency at ED admission is associated with higher mortality and longer hospital stay in patients with severe sepsis.

[1]  S. Gryspeerdt,et al.  Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality , 2020, American journal of clinical pathology.

[2]  Jong Deog Lee,et al.  Serum vitamin D binding protein level, but not serum total, bioavailable, free vitamin D, is higher in 30-days survivors than in nonsurvivors with sepsis , 2020, Medicine.

[3]  Xiangbing Wang,et al.  High-Dose Vitamin D3 for Critically Ill Vitamin D-Deficient Patients. , 2020, The New England journal of medicine.

[4]  S. Ding,et al.  Serum 25-Hydroxyvitamin D and the risk of mortality in adult patients with Sepsis: a meta-analysis , 2020, BMC Infectious Diseases.

[5]  R. Hyzy,et al.  Early High-Dose Vitamin D3 for Critically Ill, Vitamin D-Deficient Patients. , 2019, The New England journal of medicine.

[6]  A. Berghold,et al.  Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study) , 2019, BMJ Open.

[7]  T. Shimazu,et al.  Serum albumin as a risk factor for death in patients with prolonged sepsis: An observational study. , 2019, Journal of critical care.

[8]  John H. White,et al.  Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions , 2018, Endocrine reviews.

[9]  H. DeLuca,et al.  Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D , 2018, British journal of clinical pharmacology.

[10]  D. Heyland,et al.  Vitamin D supplementation in the critically ill: A systematic review and meta-analysis. , 2017, Clinical nutrition.

[11]  T. Pieber,et al.  The effect of high-dose cholecalciferol on bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial , 2017, Intensive Care Medicine.

[12]  M. Antonelli,et al.  Clinical and microbiological outcome in septic patients with extremely low 25-hydroxyvitamin D levels at initiation of critical care. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[14]  Thomas J. Wang Vitamin D and Cardiovascular Disease. , 2016, Annual review of medicine.

[15]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[16]  C. Camargo,et al.  Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial , 2015, Critical care medicine.

[17]  A. Berghold,et al.  Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial. , 2014, JAMA.

[18]  T. Maeda,et al.  Prognostic implications of conversion from nonshockable to shockable rhythms in out-of-hospital cardiac arrest , 2014, Critical Care.

[19]  D. Leaf,et al.  Randomized controlled trial of calcitriol in severe sepsis. , 2014, American journal of respiratory and critical care medicine.

[20]  T. Pieber,et al.  Vitamin D status and its association with season, hospital and sepsis mortality in critical illness , 2014, Critical Care.

[21]  R. Gama,et al.  Vitamin D: a negative acute phase reactant , 2013, Journal of Clinical Pathology.

[22]  G. Martin,et al.  Vitamin D in sepsis: from basic science to clinical impact , 2012, Critical Care.

[23]  Arthur S Slutsky,et al.  Acute Respiratory Distress Syndrome The Berlin Definition , 2012 .

[24]  Michelino Di Rosa,et al.  Vitamin D3: a helpful immuno‐modulator , 2011, Immunology.

[25]  C. Gordon,et al.  Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. , 2011, The Journal of clinical endocrinology and metabolism.

[26]  A. Krishnan,et al.  Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients , 2010, Critical care.

[27]  A. Gombart The vitamin D-antimicrobial peptide pathway and its role in protection against infection. , 2009, Future microbiology.

[28]  D. Tamandl,et al.  Vitamin D3 down‐regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen‐associated molecular patterns , 2006, European journal of immunology.

[29]  D. Zehnder,et al.  Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase , 2004, Molecular and Cellular Endocrinology.

[30]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[31]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.